The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. (Q30441682)

21 June 2017

The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. (English)

1 reference

Marie-Louise Hammarskjöld

21 June 2017

8

object named as

Marie-Louise Hammarskjöld

1 reference

21 June 2017

Kevin Olivieri

1

1 reference

21 June 2017

Robert M Scoggins

2

1 reference

21 June 2017

Yeou-cherng Bor

3

1 reference

21 June 2017

Aprille Matthews

4

1 reference

21 June 2017

David Mark

5

1 reference

21 June 2017

James R Taylor

6

1 reference

21 June 2017

David Chernauskas

7

1 reference

21 June 2017

David Rekosh

9

1 reference

21 June 2017

David Camerini

10

1 reference

21 June 2017

language of work or name

English

0 references

publication date

26 September 2006

1 reference

21 June 2017

16

1 reference

inferred from page(s)

published in

Virology

1 reference

21 June 2017

358

1 reference

21 June 2017

1

1 reference

21 June 2017

23-38

1 reference

Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Determinants of HIV-1 coreceptor function on CC chemokine receptor 3. Importance of both extracellular and transmembrane/cytoplasmic regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Biologic features of HIV-1 that correlate with virulence in the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Biological cloning of functionally diverse quasispecies of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Capture of an early fusion-active conformation of HIV-1 gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The HIV Env-mediated fusion reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Using CLUSTAL for multiple sequence alignments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 in fetal lymphoid organs: implications for pathogenesis in utero

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Increased In Vitro Cytopathicity of CC Chemokine Receptor 5–Restricted Human Immunodeficiency Virus Type 1 Primary Isolates Correlates with a Progressive Clinical Course of Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Energetics of the HIV gp120-CD4 binding reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Indel-based evolutionary distance and mouse-human divergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Atomic structure of the ectodomain from HIV-1 gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

The antigenic structure of the HIV gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Role of hydrophobic residues in the central ectodomain of gp41 in maintaining the association between human immunodeficiency virus type 1 envelope glycoprotein subunits gp120 and gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

7 January 2021

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

7 January 2021

The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

7 January 2021

Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

7 January 2021

Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.027

7 January 2021

10.1016/J.VIROL.2006.08.027

Identifiers

DOI

1 reference

release_76ec4ce33fdiblqpnjjweq5i24

21 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/76ec4ce33fdiblqpnjjweq5i24

24 November 2022

mapped directly with Wikidata item

1 reference